Ovarian Cancer
Findings in Ovarian Cancer Reported from University of British Columbia
Published in Women's Health Weekly, September 22nd, 2011
2011 SEP 22 -- New research, "E-cadherin inhibits tumor cell growth by suppressing PI3K/Akt signaling via ß-catenin-Egr1-mediated PTEN expression," is the subject of a report. According to the authors of recent research from Vancouver, Canada, "E-cadherin is a cell-cell adhesion protein and tumor suppressor that is silenced in many malignancies. E-cadherin is thought to suppress tumor cell growth by antagonizing ß-catenin signaling."
"However, the role of E-cadherin in ovarian cancer progression is still controversial. In this study, we showed that loss of E-cadherin induced ovarian cancer cell growth and constitutive activation of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Breast Cancer Drug Discoveries 2011: What the Future Holds - Breast Cancer
Findings from Johns Hopkins University School of Medicine Provide New Insights into Breast Cancer - Breast Cancer
Findings from University Health Network in Breast Cancer Reported - Breast Cancer
Findings from University Medical Center Broaden Understanding of Breast Cancer - Breast Cancer
Flaxseed no help for hot flashes during breast cancer or menopause, study finds - Breast Cancer
Investigators at University Hospital Target Breast Cancer - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
